Speaker illustration

Doctor Rafaela Del Carmen Ramirez Rodriguez

University Hospital of Gran Canaria Doctor Negrin, Las Palmas de Gran Canaria (Spain)

Cardiac resynchronization therapy in diabetic patients improves survival in the group of patients with atrial fibrillation in the first twelve years. Long term follow-up.

Event: EHRA 2019

Topic: Clinical

Session: Atrial Fibrillation - Clinical

Thumbnail

Effects of cardiac resyncrhonization therapy pacemaker versus cardiac resyncrhonization therapy implantable cardioverter defibrillator. Long term follow up

Event: EHRA 2018

Topic: Cardiac Resynchronization Therapy

Session: Controverses in CRT

Thumbnail

Comparative study between upgrade and de novo cardiac resyncrhonization therapy. Long term follow up

Event: EHRA 2018

Topic: Resynchronization Therapy

Session: CRT

Thumbnail

Do we need to use cardiac resynchronization therapy pacemaker more? Comparative study to cardiac resyncrhonization therapy defibrillator.

Event: EHRA 2018

Topic: Chronic Heart Failure – Treatment

Session: CRT

Thumbnail

Is the upgrade with respect to de novo cardiac resyncrhonization therapy effective? Long term comparative study

Event: EHRA 2018

Topic: Chronic Heart Failure – Treatment

Session: CRT

Thumbnail

Effects of upgrade versus de novo cardiac resyncrhonization therapy on clinical response. Long term survival follow up from single center.

Event: EHRA 2018

Topic: Cardiac Resynchronization Therapy

Session: CRT

Thumbnail

Could patients over 85 years benefit of cardiac resynchronization pacemaker?

Event: ESC CONGRESS 2017

Topic: Resynchronisation therapy

Session: Cardiac resynchronisation therapy

Thumbnail

Response to cardiac resyncrhonization therapy in elderly patients (85 years). Long term follow-up.

Event: EHRA EUROPACE - CARDIOSTIM 2017

Topic: Indications (Resynchronization therapy)

Session: Cardiac resynchronisation therapy

Thumbnail

Survival of patients with biventricular devices after device infection

Event: ESC CONGRESS 2016

Topic: Resynchronisation therapy

Session: Optimising results of cardiac resynchronisation therapy and clinical results and left ventricular lead placement

Thumbnail

Device infection and survival of patients with biventricular devices

Event: ESC CONGRESS 2016

Topic: Heart failure, other

Session: Heart failure/Left ventricular function

Thumbnail

This platform is supported by

logo Novo Nordisk